Intrinsic Imaging Awarded International Phase II Study for Novel Vascular Medical Device

Boston, MA / San Antonio, TX — August 21, 2014 — Intrinsic Imaging, an FDA audited, ISO 13485 and 9001 certified imaging core lab specializing in providing imaging core lab services for clinical trials, announced today that it has been awarded an international Phase II study for a novel vascular medical device. Throughout this trial, Intrinsic Imaging will provide comprehensive imaging core lab services including specialized radiologic review and analysis of all medical device images.

Intrinsic Imaging's medical device team is led by full-time board-certified, fellowship-trained interventional radiologists with extensive experience in numerous medical devices across a variety of therapeutic areas, including but not limited to cardiovascular, central nervous system, GI & genitourinary, musculoskeletal and oncology.